Sunshine Biopharma(US:SBFM) Accessnewswire·2025-10-16 11:45Core Viewpoint - Sunshine Biopharma Inc. has launched Pravastatin, a generic version of Pravachol®, through its Canadian subsidiary, Nora Pharma Inc., expanding its portfolio in the pharmaceutical market focused on life-saving medicines [1] Company Summary - Sunshine Biopharma Inc. is a pharmaceutical company engaged in the research and development of medicines across various therapeutic areas, including oncology and antivirals [1] - The launch of Pravastatin positions the company within the Lipid Metabolism Regulators therapeutic class, indicating a strategic move to enhance its product offerings [1] Industry Summary - The introduction of generic drugs like Pravastatin is significant in the pharmaceutical industry as it can lead to increased accessibility and affordability of essential medications for patients [1] - The market for lipid metabolism regulators is competitive, and the entry of new generic options may impact pricing and market share dynamics [1]